Online citations, reference lists, and bibliographies.
← Back to Search

Recent Advancements In Non-Invasive Formulations For Protein Drug Delivery

Rajiv Bajracharya, Jae Geun Song, Seung Yun Back, Hyokyung Han
Published 2019 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Advancements in biotechnology and protein engineering expand the availability of various therapeutic proteins including vaccines, antibodies, hormones, and growth factors. In addition, protein drugs hold many therapeutic advantages over small synthetic drugs in terms of high specificity and activity. This has led to further R&D investment in protein-based drug products and an increased number of drug approvals for therapeutic proteins. However, there are many biological and biopharmaceutical obstacles inherent to protein drugs including physicochemical and enzymatic destabilization, which limit their development and clinical application. Therefore, effective formulations of therapeutic proteins are needed to overcome the various physicochemical and biological barriers. In current medical practice, protein drugs are predominantly available in injectable formulations, which have disadvantages including pain, the possibility of infection, high cost, and low patient compliance. Consequently, non-invasive drug delivery systems for therapeutic proteins have gained great attention in the research and development of biomedicines. Therefore, this review covers the various formulation approaches to optimizing the delivery properties of protein drugs with an emphasis on improving bioavailability and patient compliance. It provides a comprehensive update on recent advancements in nanotechnologies with regard to non-invasive protein drug delivery systems, which is also categorized by the route of administrations including oral, nasal, transdermal, pulmonary, ocular, and rectal delivery systems.
This paper references
10.1002/btm2.10015
Intestinal mucoadhesive devices for oral delivery of insulin
Amrita Banerjee (2016)
10.1016/j.addr.2008.11.002
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.
S. Lai (2009)
10.4155/tde.15.75
Nanostructured materials for ocular delivery: nanodesign for enhanced bioadhesion, transepithelial permeability and sustained delivery.
J. Kim (2015)
10.4103/0250-474X.95608
Noninvasive Routes of Proteins and Peptides Drug Delivery
Jitendra (2011)
10.1007/s40005-016-0300-x
Application of d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) in transdermal and topical drug delivery systems (TDDS)
C. V. Pham (2016)
10.2147/IJN.S109552
Promotion of the transdermal delivery of protein drugs by N-trimethyl chitosan nanoparticles combined with polypropylene electret
Y. Tu (2016)
10.1021/bm2017355
Effective gene delivery using stimulus-responsive catiomer designed with redox-sensitive disulfide and acid-labile imine linkers.
X. Cai (2012)
10.1021/mp100210g
Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?
B. Slütter (2010)
10.5936/csbj.201209002
Computational approaches for rational design of proteins with novel functionalities
M. Tiwari (2012)
10.1016/j.bbrc.2010.03.041
Investigation of archaeosomes as carriers for oral delivery of peptides.
Z. Li (2010)
10.1007/s40005-016-0289-1
Nanostructured polysaccharide-based carriers for antimicrobial peptide delivery
Shahab Mohtashamian (2016)
Review Article As A Review on Hydrogels as Drug Delivery in the Pharmaceutical Field
B. Sri (2012)
10.1016/j.colsurfb.2018.08.021
Methylcellulose and polyacrylate binary hydrogels used as rectal suppository to prevent type I diabetes.
Jintao Xue (2018)
10.1002/biot.201600081
Solid‐in‐oil nanodispersions for transdermal drug delivery systems
Momoko Kitaoka (2016)
10.1016/j.jconrel.2015.07.007
Dexamethasone nanowafer as an effective therapy for dry eye disease.
Terry G. Coursey (2015)
Global markets for bioengineered protein drugs Available https:// www.bccresearch.com
SS Dewan (2017)
10.1016/j.jconrel.2017.09.017
Hollow microneedle‐mediated intradermal delivery of model vaccine antigen‐loaded PLGA nanoparticles elicits protective T cell‐mediated immunity to an intracellular bacterium
A. M. de Groot (2017)
As a review on hydrogels as drug delivery in the pharmaceutical field
B Sri (2012)
10.1016/j.msec.2018.10.040
Encapsulation of bovine serum albumin within novel xanthan gum based hydrogel for protein delivery.
M. Sabaa (2019)
10.1088/1758-5090/8/1/015006
Development of a drug-coated microneedle array and its application for transdermal delivery of interferon alpha.
K. Kusamori (2016)
10.1007/s40005-017-0344-6
Self microemulsifying particles of loratadine for improved oral bioavailability: preparation, characterization and in vivo evaluation
K. V. Madhav (2017)
10.1007/s40005-017-0308-x
Enhancement of in vitro dissolution and pharmacodynamic potential of olanzapine using solid SNEDDS
M. Ahsan (2017)
Anti-Flt1peptide–hyaluronate conjugate for the treatment of retinal neovascularization and diabetic retinopathy
EJ Oh (2011)
Enhancement of invitro dissolution and pharmacodynamic potential of olanzapine using solid SNEDDS
MN Ahsan (2018)
10.1208/s12249-010-9390-3
Insulin-Loaded Nanoparticles Based on N-Trimethyl Chitosan: In Vitro (Caco-2 Model) and Ex Vivo (Excised Rat Jejunum, Duodenum, and Ileum) Evaluation of Penetration Enhancement Properties
G. Sandri (2010)
10.1001/jamaophthalmol.2015.4331
Effect of Regulatory Requirement for Patient-Specific Prescriptions for Off-Label Medications on the Use of Intravitreal Bevacizumab.
S. Holfinger (2016)
10.1016/b978-0-12-384964-9.00012-8
Other Routes of Protein and Peptide Delivery
B. Shah (2011)
10.4155/TDE.12.40
Polymer-based oral peptide nanomedicines.
E. P. Herrero (2012)
10.4155/tde.13.104
Basics and recent advances in peptide and protein drug delivery.
Benjamin J. Bruno (2013)
10.1016/j.biomaterials.2012.08.070
Airway delivery of peptides and proteins using nanoparticles.
C. Dombu (2013)
10.1166/JBN.2016.2278
A pH-Sensitive Nanosystem Based on Carboxymethyl Chitosan for Tumor-Targeted Delivery of Daunorubicin.
X. Zhang (2016)
10.1513/PATS.200409-049TA
The lungs as a portal of entry for systemic drug delivery.
John S. Patton (2004)
10.4155/tde.14.111
Challenges in the delivery of peptide drugs: an industry perspective.
A. Lewis (2015)
10.1016/j.ejpb.2009.09.004
Nano-sized water-in-oil-in-water emulsion enhances intestinal absorption of calcein, a high solubility and low permeability compound.
K. Koga (2010)
10.1517/17425247.2012.666968
Liposomes in cosmeceutics
Yahya Rahimpour (2012)
10.1126/scitranslmed.3007049
Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery
Eric M. Pridgen (2013)
Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving invivo ocular bioavailability
R Liu (2012)
10.1016/j.ijbiomac.2014.08.040
pH-sensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin delivery.
Piyasi Mukhopadhyay (2015)
10.1016/j.addr.2018.01.008
Ocular delivery of proteins and peptides: Challenges and novel formulation approaches☆
A. Mandal (2018)
10.1021/acs.molpharmaceut.5b00828
Composite Nanoformulation Therapeutics for Long-Term Ocular Delivery of Macromolecules.
Vibhuti Agrahari (2016)
10.1136/gut.2009.184556
Targeting delivery of anti-TNFα oligonucleotide into activated colonic macrophages protects against experimental colitis
L. Zuo (2009)
10.1016/j.jsps.2014.06.004
A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives
Abdul Muheem (2016)
10.1021/ACS.IECR.5B01193
Complexation Hydrogels as Oral Delivery Vehicles of Therapeutic Antibodies: An in Vitro and ex Vivo Evaluation of Antibody Stability and Bioactivity.
Brenda R Carrillo-Conde (2015)
10.1016/j.addr.2016.02.004
Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials.
T. A. Aguirre (2016)
10.1007/s11095-007-9308-2
Transdermal Delivery of Interferon Alpha-2B using Microporation and Iontophoresis in Hairless Rats
A. Badkar (2007)
10.1016/j.ijpharm.2011.02.047
Self-double-emulsifying drug delivery system (SDEDDS): a new way for oral delivery of drugs with high solubility and low permeability.
X. Qi (2011)
10.1016/j.nano.2011.08.018
Polyamidoamine dendrimer hydrogel for enhanced delivery of antiglaucoma drugs.
C. A. Holden (2012)
10.1208/s12249-011-9601-6
Transdermal Delivery of Proteins
Haripriya Kalluri (2011)
10.1007/s40005-019-00439-x
Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)/poly(lactic-co-glycolic acid) micro and nanoparticles
Enas M. Elmowafy (2019)
10.1016/j.biomaterials.2011.01.003
Anti-Flt1 peptide - hyaluronate conjugate for the treatment of retinal neovascularization and diabetic retinopathy.
E. J. Oh (2011)
10.1007/s40005-017-0369-x
Potential of different salt forming agents on the formation of chitosan nanoparticles as carriers for protein drug delivery systems
M. Luangtana-Anan (2017)
10.1038/nmat2784
Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines.
T. Nochi (2010)
10.1021/acsnano.7b08152
Core-Shell Microneedle Gel for Self-Regulated Insulin Delivery.
J. Wang (2018)
10.1155/2013/732340
Dendrimeric Systems and Their Applications in Ocular Drug Delivery
B. Yavuz (2013)
10.1016/j.biomaterials.2015.11.057
Ionizing radiation-engineered nanogels as insulin nanocarriers for the development of a new strategy for the treatment of Alzheimer's disease.
P. Picone (2016)
10.2147/IJN.S132456
Enhanced immunization via dissolving microneedle array-based delivery system incorporating subunit vaccine and saponin adjuvant
J. Zhao (2017)
10.1016/j.drudis.2010.03.011
New strategies to improve the intranasal absorption of insulin.
X. Duan (2010)
10.1016/j.addr.2018.12.006
Advances in transdermal insulin delivery.
Y. Zhang (2018)
10.1016/j.biomaterials.2010.07.111
Tuneable semi-synthetic network alginate for absorptive encapsulation and controlled release of protein therapeutics.
A. Chan (2010)
Global markets for bioengineered protein drugs Available https:// www.bccresearch.com
SS Dewan (2017)
10.1016/j.jconrel.2014.06.043
Ocular delivery of macromolecules.
Y. C. Kim (2014)
10.1016/j.jconrel.2017.11.049
Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: Formulation development, stability issues, basic considerations and applications
Vineet Kumar Rai (2018)
10.1021/nn506599f
Ocular drug delivery nanowafer with enhanced therapeutic efficacy.
X. Yuan (2015)
10.1016/j.xphs.2016.10.001
Recent Advances in Lipid-Based Vesicles and Particulate Carriers for Topical and Transdermal Application.
Shashank Jain (2017)
10.1016/j.ijpharm.2017.09.043
Protein-loaded emulsion electrospun fibers optimized for bioactivity retention and pH-controlled release for peroral delivery of biologic therapeutics.
H. Frizzell (2017)
10.1007/s40005-017-0304-1
Mesalamine-loaded alginate microspheres filled in enteric coated HPMC capsules for local treatment of ulcerative colitis: in vitro and in vivo characterization
V. C. Patole (2017)
10.1007/s40005-019-00443-1
Poly(lactic acid)/poly(lactic-co-glycolic acid) particulate carriers for pulmonary drug delivery
F. Emami (2019)
10.1016/j.tibtech.2009.07.009
Therapeutic application of peptides and proteins: parenteral forever?
Zuzana Antošová (2009)
10.2174/1385272820666160510154557
Redox-Sensitive Smart Nanosystems for Drug and Gene Delivery
Mahdi Karimi (2016)
10.1080/19420862.2015.1115937
Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and development
J. Tibbitts (2016)
10.1139/CJC-2017-0198
Dendrimer and dendrimer–conjugate protein complexes and protein coronas
J. Chen (2017)
10.1016/j.ijpharm.2013.02.006
Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant.
L. Guo (2013)
10.1007/978-1-4614-9524-6_8
Nasal Delivery of Biopharmaceuticals
E. Yuba (2014)
10.1007/s40005-018-00422-y
Casein-based hydrogel carrying insulin: preparation, in vitro evaluation and in vivo assessment
E. Khodaverdi (2018)
10.1039/c8nr04073g
Treatment of neurodegenerative disorders through the blood-brain barrier using nanocarriers.
N. Poovaiah (2018)
10.1038/s41598-018-19170-y
Fc-modified exenatide-loaded nanoparticles for oral delivery to improve hypoglycemic effects in mice
Y. Shi (2018)
10.1007/s40005-017-0365-1
Pharmaceutical and pharmacokinetic evaluation of novel rectal mucoadhesive hydrogels containing tolmetin sodium
Afaf A. Ramadan (2017)
10.1039/C2MD20059G
Transdermal delivery of insulin using a solid-in-oil nanodispersion enhanced by arginine-rich peptides
Y. Tahara (2012)
10.1166/JBN.2016.2279
Redox Sensitive Shell and Core Crosslinked Hyaluronic Acid Nanocarriers for Tumor-Targeted Drug Delivery.
Hua Zheng (2016)
10.1139/cjc-2017-0193
Dendrimers for Ocular Drug Delivery.
Michael G. Lancina (2017)
10.1016/j.actbio.2014.01.033
Polymeric nanoparticles for pulmonary protein and DNA delivery.
Jyothi U Menon (2014)
10.5402/2011/780150
Development and Evaluation of Microemulsions for Transdermal Delivery of Insulin
J. Malakar (2011)
10.1016/j.jconrel.2008.12.018
Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
R. C. Nagarwal (2009)
10.1016/j.jconrel.2015.11.009
Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation.
Kruti S Soni (2016)
10.1007/s40005-018-0384-6
Physicochemical characterization and cytotoxicity of chitosan-modified single walled carbon nanotubes as drug carriers
X. Zhang (2018)
Pluronic P 85 / poly ( lactic acid ) vesicles as novel carrier for oral insulin delivery
XY Xiong (2013)
10.1016/j.nano.2011.05.006
Computational approaches to the rational design of nanoemulsions, polymeric micelles, and dendrimers for drug delivery.
Loan Huynh (2012)
10.1016/j.ejpb.2016.11.029
Complexation hydrogels as potential carriers in oral vaccine delivery systems
Mia Yoshida (2017)
10.1517/17425247.2013.797405
Microarrays and microneedle arrays for delivery of peptides, proteins, vaccines and other applications
S. Chandrasekhar (2013)
10.1016/j.ejps.2012.01.002
Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
X. Zhang (2012)
10.1016/j.lfs.2016.11.015
Application of carbon nanotubes as the carriers of the cannabinoid, 2‐arachidonoylglycerol: Towards a novel treatment strategy in colitis
P. Hassanzadeh (2017)
10.1111/j.1463-1326.2011.01546.x
Preparation, characterization and in vivo evaluation of pH‐sensitive oral insulin‐loaded poly(lactic‐co‐glycolicacid) nanoparticles
J. Yang (2012)
10.4155/tde-2016-0031
What is the future of noninvasive routes for protein- and peptide-based drugs?
Sameer Sachdeva (2016)
10.1016/j.colsurfb.2009.09.001
Biodegradable polymeric nanoparticles based drug delivery systems.
A. Kumari (2010)
Anti-Flt1peptide–hyaluronate conjugate for the treatment of retinal neovascularization and diabetic retinopathy
EJ Oh (2011)
10.1016/j.colsurfb.2012.06.024
Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats.
N. Khalil (2013)
Pharmacokinetics of curcumin-loadedPLGA and PLGA–PEG blend nanoparticles after oral administration in rats
NM Khalil (2013)
10.1007/s13346-012-0111-1
Nasal drug delivery
E. Touitou (2012)
10.1016/J.JDDST.2017.12.006
Development and characterization of gels and liposomes containing ovalbumin for nasal delivery
M. Kaplan (2018)
10.1016/j.jconrel.2017.01.012
Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies
A. Mandal (2017)
10.1016/j.diabres.2017.11.018
Nanotechnology based approaches for anti-diabetic drugs delivery.
P. Kesharwani (2018)
10.1016/J.CCLET.2018.10.037
Nano-formulations for transdermal drug delivery: A review
Xing-Li Zhou (2018)
10.2217/nnm-2018-0112
Gene delivery in the cornea: in vitro & ex vivo evaluation of solid lipid nanoparticle-based vectors.
M. Vicente-Pascual (2018)
10.1007/s40005-017-0372-2
Polymeric nanomedicines for poorly soluble drugs in oral delivery systems: an update
Xiangyu Ma (2017)
10.1016/j.ijpharm.2018.11.032
Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases
Prerana Carter (2019)
10.1007/s11596-010-0661-8
Targeting therapy of choroidal neovascularization by use of polypeptide- and PEDF-loaded immunoliposomes under ultrasound exposure
Tao Li 李 涛 (2010)
10.1016/B978-0-12-384935-9.10005-7
Ocular Delivery of Peptides and Proteins
S. P. Vyas (2011)
10.1016/j.ijpharm.2017.09.017
Designing lipid nanoparticles for topical ocular drug delivery.
J. Álvarez-Trabado (2017)
10.1038/nchembio.2006
Protein aggregation: A rescue by chaperones.
J. Schymkowitz (2016)
10.3109/10717544.2014.951102
Penetration depth, concentration and efficiency of transdermal α-arbutin delivery after ultrasound treatment with albumin-shelled microbubbles in mice
A. Liao (2016)
10.1007/s40005-017-0318-8
Microemulsion for nasal delivery of Asenapine maleate in treatment of schizophrenia: formulation considerations
Mrunali R. Patel (2017)
10.1016/S1773-2247(13)50055-4
Mucosal drug delivery: barriers, in vitro models and formulation strategies
M. Boegh (2013)
10.1016/j.actbio.2016.05.011
Thermosensitive hexanoyl glycol chitosan-based ocular delivery system for glaucoma therapy.
Ik Sung Cho (2016)
10.1007/s40005-019-00442-2
PEGylated polylactide (PLA) and poly (lactic-co-glycolic acid) (PLGA) copolymers for the design of drug delivery systems
D. R. Perinelli (2019)
10.1016/j.actbio.2015.06.021
Poly-γ-glutamic acid microneedles with a supporting structure design as a potential tool for transdermal delivery of insulin.
M. Chen (2015)
Recent Advances in Novel Drug Carrier Systems
Y. Javadzadeh (2012)
10.1166/JBN.2017.2407
Synthesis and In Vitro Characterization of Carboxymethyl Chitosan-CBA-Doxorubicin Conjugate Nanoparticles as pH-Sensitive Drug Delivery Systems.
R. Hu (2017)
10.1097/MJT.0000000000000198
Electroporation Parameters for Successful Transdermal Delivery of Insulin
E. A. Mohammad (2016)
10.22270/JDDT.V8I5-S.1981
TRANSFEROSOME: A RECENT APPROACH FOR TRANSDERMAL DRUG DELIVERY
A. Kumar (2018)
10.1007/s40005-017-0316-x
Nutraceutical emulsion containing valproic acid (NE-VPA): a drug delivery system for reversion of seizures in zebrafish larvae epilepsy model
D. A. Feas (2017)
10.2147/IJN.S46748
Enhanced transdermal bioavailability of testosterone propionate via surfactant-modified ethosomes
S. Meng (2013)
10.1002/jbm.a.36305
Intestinal organoids containing poly(lactic-co-glycolic acid) nanoparticles for the treatment of inflammatory bowel diseases.
Z. Davoudi (2018)
10.1016/j.addr.2018.01.015
Polymeric microneedles for transdermal protein delivery☆
Yanqi Ye (2018)
10.1002/jbm.b.31161
Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin.
X. Wang (2009)
10.1002/jps.24182
Microneedles for drug delivery via the gastrointestinal tract.
G. Traverso (2015)
10.1016/J.MTCHEM.2018.09.001
Rectal administration of nanosystems: from drug delivery to diagnostics
Mélanie Melo (2018)
10.1021/CR050247K
Hyaluronidases: their genomics, structures, and mechanisms of action.
Robert H. Stern (2006)
10.1016/j.vaccine.2015.06.054
Elastic liposome-mediated transdermal immunization enhanced the immunogenicity of P. falciparum surface antigen, MSP-119.
Rajeev K. Tyagi (2015)
10.1016/j.drudis.2010.08.007
Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability.
K. Kohli (2010)
10.5772/50314
Nanocarrier Systems for Transdermal Drug Delivery
José Juan Escobar-Chávez (2012)
10.1016/j.ijpharm.2016.11.037
Microencapsulated SLN: An innovative strategy for pulmonary protein delivery.
Diana P Gaspar (2017)
10.3390/molecules23061241
Design and Efficacy of Nanogels Formulations for Intranasal Administration
B. Aderibigbe (2018)
10.1007/s11051-012-1219-4
Concanavalin A conjugated biodegradable nanoparticles for oral insulin delivery
P. Hurkat (2012)
10.1186/1556-276X-6-555
The application of carbon nanotubes in target drug delivery systems for cancer therapies
Wuxu Zhang (2011)
10.3390/molecules21081002
Stimuli-Responsive Polymeric Systems for Controlled Protein and Peptide Delivery: Future Implications for Ocular Delivery
Pakama Mahlumba (2016)
Global markets for bioengineered protein drugs Available
S S Dewan (2017)
Food & Drug Administration's Center for drug evaluation and research. Advancing health through innovation
(2018)
10.1016/J.REACTFUNCTPOLYM.2010.10.002
Oral protein delivery: Current status and future prospect
K. Park (2011)
10.1016/j.vaccine.2011.05.015
Archaeosomes with encapsulated antigens for oral vaccine delivery.
Z. Li (2011)
10.1016/j.jconrel.2017.03.041
A self‐adherent, bullet‐shaped microneedle patch for controlled transdermal delivery of insulin
Keum-Yong Seong (2017)
10.1016/j.jconrel.2015.10.002
IgG-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery.
J. Mönkäre (2015)
10.1002/jps.24681
Pulmonary Delivery of Proteins Using Nanocomposite Microcarriers.
Iman M. Alfagih (2015)
10.4155/tde-2017-0024
Challenges in oral peptide delivery: lessons learnt from the clinic and future prospects.
J. Richard (2017)
10.1016/j.jdermsci.2017.06.012
Transcutaneous immunization with a novel imiquimod nanoemulsion induces superior T cell responses and virus protection.
P. A. Lopez (2017)
10.1016/j.biopha.2018.10.078
Microneedles: A smart approach and increasing potential for transdermal drug delivery system.
Tejashree Waghule (2019)
10.2217/nnm.10.143
Nanocarriers for pulmonary administration of peptides and therapeutic proteins.
Fernanda Andrade (2011)
10.3390/ijms17060853
Identification of Protein–Excipient Interaction Hotspots Using Computational Approaches
Teresa S. Barata (2016)
10.1016/J.MOLLIQ.2018.04.002
pH-responsive alginate-based hydrogels for protein delivery
D. S. Lima (2018)
10.1016/j.biochi.2016.07.003
Liposomal constructs for antitumoral vaccination by the nasal route.
Zahra Kakhi (2016)
10.1016/j.jconrel.2016.09.008
Transdermal delivery from liposomal formulations - Evolution of the technology over the last three decades.
Mukul Ashtikar (2016)
10.1016/j.ejpb.2010.12.008
In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery.
Abdallah Makhlof (2011)
10.1016/j.jconrel.2017.10.005
Novel bilayer dissolving microneedle arrays with concentrated PLGA nano‐microparticles for targeted intradermal delivery: Proof of concept
Lalit Vora (2017)
10.1517/14712598.4.6.881
Hydrogels for oral delivery of therapeutic proteins
N. Peppas (2004)
10.1208/s12248-015-9719-7
Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases
M. E. Meredith (2015)
10.1021/NN301873V
Hybrid dendrimer hydrogel/PLGA nanoparticle platform sustains drug delivery for one week and antiglaucoma effects for four days following one-time topical administration.
H. Yang (2012)
10.1002/smll.201700164
Dissolving Microneedle Arrays for Transdermal Delivery of Amphiphilic Vaccines.
Myunggi An (2017)
10.1016/j.ijpharm.2018.10.029
Advanced formulations for intranasal delivery of biologics
J. Rohrer (2018)
10.1016/j.ijpharm.2013.02.030
Approaches for enhancing oral bioavailability of peptides and proteins.
J. Renukuntla (2013)
10.1002/jps.23251
Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
R. Liu (2012)
10.1007/s40005-018-00418-8
Potential of nanoparticulate carriers for improved drug delivery via skin
Alam Zeb (2018)
TRANSDERMAL PATCHES OF CHITOSAN NANOPARTICLES FOR INSULIN DELIVERY
Lingheswar Sadhasivam (2015)
10.1016/j.ultras.2013.07.007
Sonophoresis in transdermal drug deliverys.
D. Park (2014)
10.1016/j.drudis.2007.10.021
Nanotechnology in ocular drug delivery.
S. Sahoo (2008)
10.1016/j.ijbiomac.2013.08.002
Combining two technologies: multifunctional polymers and self-nanoemulsifying drug delivery system (SNEDDS) for oral insulin administration.
D. Sakloetsakun (2013)
10.1002/jps.21674
Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake.
S. R. K. Vaka (2009)
10.1016/B978-0-12-814031-4.00021-0
Administration Routes for Nano Drugs and Characterization of Nano Drug Loading
V. Nikolic (2019)
10.2174/1381612821666150821112808
Nanocarriers in Improved Heparin Delivery: Recent Updates.
B. D. Kurmi (2015)
10.1016/j.ijbiomac.2018.09.044
Insulin-loaded hydroxypropyl methyl cellulose-co-polyacrylamide-co-methacrylic acid hydrogels used as rectal suppositories to regulate the blood glucose of diabetic rats.
Yongli Shi (2019)
10.1016/j.jconrel.2012.01.042
Microneedle technologies for (trans)dermal drug and vaccine delivery.
K. van der Maaden (2012)
10.1016/j.ejps.2013.07.006
The effect of polymer coatings on physicochemical properties of spray-dried liposomes for nasal delivery of BSA.
K. Chen (2013)
10.1016/j.colsurfb.2013.02.032
In vitro and computational studies of transdermal perfusion of nanoformulations containing a large molecular weight protein.
M. Martins (2013)
10.1016/j.biomaterials.2011.10.075
Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
Y. Jin (2012)
10.4103/0970-2113.92361
Pulmonary drug delivery strategies: A concise, systematic review
J. Patil (2012)
10.1016/j.ejpb.2018.05.031
Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery
J. Mönkäre (2018)
10.1016/B978-0-323-50878-0.00015-X
Functionalized Polymeric Nanostructures for Mucosal Drug Delivery
Lungile Nomcebo Thwala (2018)
10.1016/j.ejpb.2018.06.029
Surface modification with polyethylene glycol enhances colorectal distribution and retention of nanoparticles
Rute Nunes (2018)
10.3109/03639045.2012.763137
Development and in vitro evaluation of a nanoemulsion for transcutaneous delivery
Grace A. Ledet (2014)
10.1016/j.msec.2012.09.001
Oral insulin delivery by self-assembled chitosan nanoparticles: in vitro and in vivo studies in diabetic animal model.
Piyasi Mukhopadhyay (2013)
10.1186/rr58
The lung as a route for systemic delivery of therapeutic proteins and peptides
R. Uchenna Agu (2001)
10.1038/nmat3776
Stimuli-responsive nanocarriers for drug delivery.
S. Mura (2013)
Synthesis and invitro characterization of carboxymethyl chitosan-CBA-doxorubicin conjugate nanoparticles as pH-sensitive drug delivery systems
R Hu (2017)
pHsensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin delivery
P Mukhopadhyay (2015)
10.3109/10717544.2015.1052863
A review of biodegradable polymeric systems for oral insulin delivery
Y. Luo (2016)
Pharmaceutical and pharmacokinetic evaluation of novel rectal mucoadhesive hydrogels containing tolmetin sodium
AA Ramadan (2018)
10.1016/j.bbamem.2016.02.028
Computational and experimental approaches for investigating nanoparticle-based drug delivery systems.
M. Ramezanpour (2016)
10.1016/J.ADDR.2003.10.017
Drug targeting to the colon with lectins and neoglycoconjugates.
T. Minko (2004)
10.1016/j.colsurfb.2013.06.019
Pluronic P85/poly(lactic acid) vesicles as novel carrier for oral insulin delivery.
X. Y. Xiong (2013)
10.1016/j.ejps.2010.01.006
Lyophilization of water-in-oil emulsions to prepare phospholipid-based anhydrous reverse micelles for oral peptide delivery.
Ting Wang (2010)
10.1007/s40005-017-0303-2
Enhanced topical delivery of fish scale collagen employing negatively surface-modified nanoliposome
Joeun Seo (2017)
10.1016/S0378-5173(03)00337-5
Electronically facilitated transdermal delivery of human parathyroid hormone (1-34).
Babu M. Medi (2003)
10.1016/j.actbio.2018.09.013
Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats.
Jiangwei Chen (2018)
10.1039/C5MD00378D
Ionic liquid-mediated transcutaneous protein delivery with solid-in-oil nanodispersions
S. Araki (2015)
10.1016/j.intimp.2016.08.007
Immunological evaluation of colonic delivered Hepatitis B surface antigen loaded TLR-4 agonist modified solid fat nanoparticles.
K. Sahu (2016)
10.1016/j.jsps.2012.02.001
Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery.
J. Malakar (2012)
10.1016/j.drudis.2018.11.018
Computational modeling for formulation design.
C. H. Mehta (2019)
10.3390/ma11071125
Therapeutic Contact Lenses with Polymeric Vehicles for Ocular Drug Delivery: A Review
S. W. Choi (2018)
10.1002/jps.22054
Delivery of therapeutic proteins.
D. Pisal (2010)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar